Vor Biopharma Inc. (VOR) Form 8-K — Jul 7, 2026

$VORForm 8-KItems 5.02Filed Jul 7, 2026, 4:04 PM ET0001193125-26-297454Original filing

Andrew Levin, M.D., Ph.D. resigned from the Board of Directors of Vor Biopharma Inc. effective July 6, 2026. The resignation was not due to any disagreement with the Company.

Key figures

Director Cash Retainer: 40000
Annual Option Grant Value: 350000
Annual Option Grant Shares: 34000
Initial Option Grant Value: 700000
Initial Option Grant Shares: 68000

Price after filing

1 day: 0.0%7 days: -8.0%30 days: +10.8%

Close on the filing date to close N calendar days later (from $20.10). Historical, not a forecast.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.